As we look back on 2023, we are grateful to reflect on another impactful year with Brain Tumour Foundation of Canada. We are filled with gratitude for the enduring support of our donors, fundraisers, volunteers, healthcare professionals, and dedicated staff. Together, we have made remarkable strides in advancing our mission, but there is still much work to be done.
How you fundraised,In 2024 and beyond, we are committed to continuing this journey alongside our incredible community, making a positive impact on the lives of those affected by brain tumours. Thank you for everything you do to lift the burden of a brain tumour. Thank you for putting hope into action!
When a loved one hears the words, “you have a brain tumour”, we are all affected. Affected by a flood of emotion, feelings of expectation, and the desire to do something…anything to make things better.
Hope in Action celebrates you! It’s your actions that are making things better for your loved ones and for the Canadian brain tumour community. Your actions are fostering hope!
Read the full edition in our flipbook below or download the PDF below (8MB).
Every year donations ensure that strides are being made to support the 55,000 Canadians affected by a brain tumour.
Brain Tumour Foundation of Canada is a registered charity, (#BN118816339RR0001). It is because of the generosity of people like you that Canadians who are affected by a brain tumour have access to programs and services to meet their needs. Your donations also fund critical research into the cause of and cure for brain tumours. The organization receives no financial assistance from Provincial nor Federal Government.
Read more about the investments you have made in both the reports to the community and our audited financial statements.
Transparency in our accounting practices is a commitment we take seriously. Ultimate responsibility for governance and financial oversight rests with the Board of Directors. Our full financial statements are audited annually.
The financial statements below have been approved at Brain Tumour Foundation of Canada's Annual General Meetings.
